InvestSMART

Australian Pharmaceutical Industries Limited (ASX: API) - Announcements

DELISTED - Current share price for API : $1.530

ASX company news and announcements for Australian Pharmaceutical Industries Limited (API) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Pharmaceutical Industries Limited (API) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Pharmaceutical Industries Limited (API), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Pharmaceutical Industries Limited (API)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Notice of 2016 Annual General Meeting 9 Dec 2016 9:17AM $1.885 $1.530 fallen by 18.83%
- Letter to Shareholders - 2016 Annual General Meeting 9 Dec 2016 9:16AM $1.885 $1.530 fallen by 18.83%
- Letter to Shareholders - Final Dividend Payment 9 Dec 2016 9:15AM $1.885 $1.530 fallen by 18.83%
- Change in substantial holding from CBA 28 Nov 2016 4:43PM $1.865 $1.530 fallen by 17.96%
- Change of Director's Interest Notice 18 Nov 2016 4:52PM $1.720 $1.530 fallen by 11.05%
- Appendix 3B 18 Nov 2016 4:50PM $1.720 $1.530 fallen by 11.05%
- Change of Director's Interest Notice 28 Oct 2016 5:28PM $1.860 $1.530 fallen by 17.74%
- Change of Director's Interest Notice 27 Oct 2016 7:00PM $1.870 $1.530 fallen by 18.18%
- Appendix 3B 21 Oct 2016 3:17PM $1.933 $1.530 fallen by 20.83%
- FY16 - Results presentation 20 Oct 2016 8:27AM $1.915 $1.530 fallen by 20.10%
- FY16 Results - media release 20 Oct 2016 8:26AM $1.915 $1.530 fallen by 20.10%
- Dividend/Distribution - API 20 Oct 2016 8:25AM $1.915 $1.530 fallen by 20.10%
- Appendix 4E and FY16 Financial Report 20 Oct 2016 8:25AM $1.915 $1.530 fallen by 20.10%
- Change in substantial holding from CBA 14 Oct 2016 4:23PM $1.935 $1.530 fallen by 20.93%
- API FY16 Financial Results 14 Oct 2016 3:05PM $1.950 $1.530 fallen by 21.54%
- CEO & MD succession and FY16 forecast update 6 Oct 2016 8:30AM $1.895 $1.530 fallen by 19.26%
- Becoming a substantial holder (Amendment) 22 Jul 2016 1:22PM $1.863 $1.530 fallen by 17.85%
- API Investor Briefing - Sydney 19 July 2016 19 Jul 2016 8:48AM $1.785 $1.530 fallen by 14.29%
- Change in substantial holding from CBA 14 Jul 2016 2:38PM $1.725 $1.530 fallen by 11.30%
- Letter to shareholders - interim dividend payment 3 Jun 2016 9:33AM $1.790 $1.530 fallen by 14.53%
- Ceasing to be a substantial holder 3 Jun 2016 8:24AM $1.790 $1.530 fallen by 14.53%
- Becoming a substantial holder 2 Jun 2016 8:23AM $1.840 $1.530 fallen by 16.85%
- Becoming a substantial holder from CBA 20 May 2016 4:48PM $1.905 $1.530 fallen by 19.69%
- Ceasing to be a substantial holder 17 May 2016 8:31AM $1.890 $1.530 fallen by 19.05%
- Becoming a substantial holder 16 May 2016 8:25AM $1.880 $1.530 fallen by 18.62%

326 - 350 of 477 results

Page 14 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.